Skip to search formSkip to main contentSkip to account menu

PROM1 gene

Known as: PROML1, AC133, CD133 
This gene plays a role in myogenesis.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
CD133, also known as prominin-1, was first described as a cell surface marker on early progenitor and hematopoietic stem cells… 
2014
2014
Cancer stem cell-related (CSC) markers have been suggested to have promising potentials as novel types of prognostic and… 
Highly Cited
2013
Highly Cited
2013
Tumor-initiating cells (TIC) are critical yet evasive targets for the development of more effective antitumoral strategies. The… 
2013
2013
Chemoresistance is one of the major barriers to chemotherapeutic treatment and it has been established that CD133+ cancer stem… 
2012
2012
MicroRNAs (miRNAs) are small noncoding RNAs whose function as modulators of gene expression is crucial for the proper control of… 
Highly Cited
2011
Highly Cited
2011
Putative CD133+ brain tumor stem cells have been shown to be located in niches and as single cells. This is the first study… 
2010
2010
OBJECTIVE To detect the expression of B7-H3 and CD133 in human non-small cell lung cancer (NSCLC) specimens and lung benign… 
Highly Cited
2008
Highly Cited
2008
Brain tumour stem cells (BTSCs) are a small population of cells that has self-renewal, transplantation, multidrug resistance and… 
Review
2008
Review
2008
  • 2008
  • Corpus ID: 38320967
Prominin-1 (alias CD133) has received considerable interest because of its expression by several stem and progenitor cells… 
2002
2002
CD133 is an antigen expressed on hematopoietic progenitor cells and on some epithelial cells. We previously reported that a…